Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with LenvatinibHaruki Uojima, Wasaburo Koizumi, Makoto Chuma et al.|Liver Cancer|2019Cited by 91
<p>Safety and Efficacy of Lenvatinib Treatment in Child–Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter Analysis</p>Katsuaki Ogushi, Shin Maeda, Makoto Chuma et al.|Clinical and Experimental Gastroenterology|2020Cited by 55
Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysisMakoto Chuma, Shin Maeda, Haruki Uojima et al.|Hepatology Research|2020Cited by 38
Influence of NOS3 rs2070744 genotypes on hepatocellular carcinoma patients treated with lenvatinibShintaro Azuma, Koichiro Atsuda, Haruki Uojima et al.|Scientific Reports|2020Cited by 12
General lectures (II)Kose Segawa, Y. Shiraki, N. Okabe et al.|Gastroenterologia Japonica|1974Cited by 6